Esser S, Wolburg K, Wolburg H, Breier G, Kurzchalia T, Risau W. Vascular endothelial growth factor induces endothelial fenestrations in vitro. J Cell Biol 140: 94759, 1998. 11. Feng D, Nagy JA, Pyne K, Hammel I, Dvorak HF, Dvorak AM. Pathways of dyphylline macromolecular extravasation across microvascular endothe- lium in response to VPF/VEGF and other vasoactive mediators. Micro- circulation 6: 234, 1999. 12. Fleegal-DeMotta MA, Doghu S, Banks WA. Angiotensin II modulates BBB permeability via activation of the AT(1) receptor in brain endothelial cells.
J Cereb Blood Flow Metab 29: 640 47, 2009. 13. Goldberg PL, MacNaughton DE, Clements RT, Minnear FL, Vincent PA. p38 MAPK activation by TGF-beta1 increases MLC phosphorylation and endothelial monolayer permeability. Am J Physiol Lung Cell Mol dyphylline Physiol 282: L146 154, 2002. 14. Guo RW, Yang LX, Li MQ, Liu B, Wang XM. Angiotensin II induces NF-kappa B activation in HUVEC via the p38MAPK pathway. Peptides 27: 3269 275, 2006. 15. Harris PJ, Young JA. Dose-dependent stimulation and inhibition of proximal tubular sodium reabsorption by angiotensin II in the rat kidney. Prs Arch 367: 29597, 1977. 16. Issbrker K, Marti HH, Hippenstiel S, Springmann G, Voswinckel R, Gaumann A, Breier G, Drexler HC, Suttorp N, Clauss M. p38 MAP kinase molecular switch between VEGF-induced angiogenesis and vas- cular hyperpermeability. FASEB J 17: 26274, 2003. 17. Jaffe EA, Nachman RL, Becker CG, Minick CR. Culture of Temsirolimus 162635-04-3 human endothelial cells derived from umbilical veins. Identiation by morpho- logic and immunologic criteria. J Clin Invest 52: 2745756, 1973. 18. Jenei A, Varga S, Bene L, Matyus L, Bodnar A, Bacso Z, Pieri C, Gaspar R Jr, Farkas T, Damjanovich S. HLA class I and II antigens are partially co-clustered in the plasma membrane of human lymphoblastoid cells. Proc Natl Acad Sci USA 94: 7269 274, 1997. 19.
Keuschnigg J, Henttinen T, Auvinen K, Karikoski M, Salmi M, Jalkanen S. The prototype endothelial marker PAL-E is a leukocyte trafking molecule. Blood 114: 478 84, 2009. 20. Kroll J, Waltenberger J. The vascular endothelial growth factor receptor KDR activates multiple signal transduction pathways in porcine aortic endothelial cells. J Biol Chem 272: 325212527, 1997. 21. Lal BK, Varma S, Pappas PJ, Hobson RW, Duran WN. VEGF Temsirolimus mTOR inhibitor increases permeability of the endothelial cell monolayer by activation of PKB/Akt, endothelial nitric-oxide synthase, and MAP kinase pathways. Microvasc Res 62: 25262, 2001. 22. Lasa M, Mahtani KR, Finch A, Brewer G, Saklatvala J, Clark AR. Regulation of cyclooxygenase 2 mRNA stability by the mitogen-activated protein kinase p38 signaling cascade. Mol Cell Biol 20: 4265274, 2000. 23. Neufeld G, Cohen T, Gengrinovitch S, Poltorak Z. Vascular endothelial growth factor (VEGF) and its receptors. FASEB J 13: 9 2, 1999. 24. Newton CR, Curran B, Victorino GP. Angiotensin II type 1 receptor activation increases microvascular permeability via a calcium dependent process.
J Surg Res 123: 339, 2005. 25. Ono K, Han J. The p38 signal transduction pathway: activation and function. Cell Signal 12: 13, 2000. 26. Parton RG, Joggerst B, Simons K. Regulated internalization of caveolae. J Cell Biol 127: 1199 215, 1994. 27. Parton RG, Simons K. The multiple faces of caveolae. Nat Rev Mol Cell Biol 8: 18594, 2007. 28. Petrova TV, Makinen T, Alitalo K. Signaling via vascular endothelial growth factor Roman medicine receptors. Exp Cell Res 253: 11730, 1999. 29. Piqueras L, Kubes P, Alvarez A, O nnor E, Issekutz AC, Esplugues JV, Sanz MJ. Angiotensin II induces leukocyte-endothelial cell interac- tions in vivo via AT(1) and AT(2) receptor-mediated P-selectin upregu- lation. Circulation 102: 2118 123, 2000. 30. Roberts WG, Palade GE. Increased microvascular permeability and endothelial fenestration in
exposure to ambient ultrae particles: the role of NADPH oxidase. Toxicol. Appl. Pharmacol. 236, 18393. Nemmar, A., Vanbilloen, H., Hoylaerts, M.F., Hoet, P.H.M., Verbruggen, A., Nemery, B., 2001.